Novozymes raises full-year EBIT outlook after Q2
Aug 14 (Reuters) - Danish industrial enzymes maker Novozymes reported second quarter earnings in line with expectations on Thursday and raised its full-year outlook for operating profit growth.
The firm's operating profit increasead by 7 percent to 787 million Danish crowns (140.97 million US dollar), broadly in line with a forecast for 792 million crowns in a Reuters poll .
For the full year, the firm now sees operating profit growth of 9 to 11 percent, above a previous guidance for 8 to 10 percent, while organic revenue growth is at 6 to 9 percent, in line with the previous guidance. (1 US dollar = 5.5827 Danish crown) (Reporting by Balazs Koranyi, editing by Terje Solsvik)